Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - INTEREST INCOME & EXPENSE
Interest Income & Expense APLS - Apellis Pharmaceuticals, Inc.
29.6 M
LAST VALUE
49.47%
2 YEAR CAGR
63.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR